India's Outward FDI Reaches $7.06 Billion Amid Economic Uncertainty
India's outward FDI jump seen as uncertainty-driven, say economists
Business Standard
Image: Business Standard
India's outward foreign direct investment (FDI) surged to $7.06 billion in March 2023, marking a 156% increase from the previous month and the highest since 2021. Economists attribute this spike to uncertainties in the domestic economy, prompting investors to seek opportunities abroad, particularly in financial services.
- 01Outward FDI reached $7.06 billion in March 2023, the highest since 2021.
- 02Monthly FDI flows have ranged between $2โ7 billion since early 2024.
- 03Outbound FDI for FY26 is $48.6 billion, up from $41.6 billion in FY25.
- 04Financial services now dominate outward FDI, increasing by 12.31 percentage points since 2021.
- 05Singapore has become the preferred destination for Indian investments, while the US has declined.
Advertisement
In-Article Ad
India's outward foreign direct investment (FDI) surged to $7.06 billion in March 2023, representing a 156% increase from February and the highest monthly figure since 2021. This spike is attributed to uncertainties in the domestic economy, leading investors to explore opportunities abroad, according to former Chief Statistician Pronab Sen. Since early 2024, monthly outward FDI flows have consistently ranged between $2โ7 billion. For the financial year 2025-26 (FY26), total outbound FDI reached $48.6 billion, an increase from $41.6 billion in FY25. The sectoral composition of these investments has shifted significantly, with financial services now accounting for the largest share, up 12.31 percentage points since 2021, while manufacturing has declined by 14.52 percentage points. N R Bhanumurthy, Director of the Madras School of Economics, noted that this trend reflects India's evolution into a service-led economy. Additionally, Singapore has solidified its position as the top destination for Indian investments, while the United States has seen a decrease in its attractiveness. Sun Pharmaceutical Industries' planned acquisition of US-based Organon and Co. for $11.75 billion is one of the largest overseas investments by an Indian firm, although it is still pending implementation.
Advertisement
In-Article Ad
The surge in outward FDI indicates a shift in investment strategies among Indian businesses, reflecting their search for stability and growth opportunities abroad.
Advertisement
In-Article Ad
Reader Poll
Do you think Indian companies should increase their investments abroad?
Connecting to poll...
More about Sun Pharmaceutical Industries

Sun Pharmaceutical Secures Top Credit Ratings Amid Acquisition Plans
Business Standard โข May 7, 2026
Six Stocks Reach 52-Week Highs Amid Sensex Surge
The Economic Times โข May 6, 2026
Sun Pharma Plans $11.75 Billion Acquisition of Organon, Exploring Eurobond Financing
Business Standard โข May 4, 2026
Read the original article
Visit the source for the complete story.




